Evaluation of molecular mouse sepsis panel: new portable and rapid tests for microorganism detection in suspected blood stream infection
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1579074 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Claudia Colosimo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Microbiology, The Great Romagna Hub Laboratory, Pievesestina, Italy. Hauptthemen laut MEDLINE: Sepsis, Molecular Diagnostic Techniques, Bacteremia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Introduction
Bloodstream infections (BSIs) represent a significant public health concern, characterized by the presence of pathogens in the bloodstream, leading to serious conditions. Between 30 and 40% of BSIs evolve in sepsis, characterized by a life-threatening organ dysfunction and accompanied by a strong or dysregulated systemic immune or inflammatory response. A timely and accurate diagnosis of BSIs is crucial for ensuring effective management and treatment of critically ill patients. The diagnosis of BSIs can be initiated either from positive blood culture (BC) or directly from blood specimens using advanced diagnostic methods, these approaches are increasingly integrated into traditional diagnostic workflows.
Methods
In the context of emerging molecular methods, Alifax introduced the Molecular Mouse (MM) Sepsis Panel in 2022. This study aims to evaluate the performance of MM cartridges in detecting Gram-positive bacteria and Gram-negative bacteria, as well as their associated resistance genes, using clinical leftover positive BCs and contrived samples for low-prevalence targets. Positive BCs were collected at the Unit of Microbiology, The Great Romagna Hub Laboratory, Pievesestina, FC, Italy.
Results
Overall, MM Sepsis Panel showed excellent sensitivity (98.62%) and specificity (99.81%), confirming the system’s reliability and accuracy.
Discussion
The high diagnostic accuracy demonstrated by these tests supports their potential application as rapid diagnostic tools for blood cultures, facilitating prompt identification of pathogens and antimicrobial resistance determinants in clinical microbiology settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Microbiology, The Great Romagna Hub Laboratory, Pievesestina, Italy.
- Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-University of Bologna, Bologna, Italy.
Zitieren
APA
Colosimo, C., Montanari, M. S., Marzucco, A., Gatti, G., Puccini, L., Grumiro, L., Dionisi, L., Brandolini, M., Ingletto, L., Guerra, M., Dirani, G., Zannoli, S., Scagliarini, A., De Pascali, A. M., Sambri, V., & Cricca, M. (2025). Evaluation of molecular mouse sepsis panel: new portable and rapid tests for microorganism detection in suspected blood stream infection. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1579074
Vancouver
Colosimo C, Montanari MS, Marzucco A, Gatti G, Puccini L, Grumiro L, et al. Evaluation of molecular mouse sepsis panel: new portable and rapid tests for microorganism detection in suspected blood stream infection. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1579074
BibTeX
@article{Colosimo2025,
author = {Colosimo, Claudia and Montanari, Maria Sofia and Marzucco, Anna and Gatti, Giulia and Puccini, Lucrezia and Grumiro, Laura and Dionisi, Laura and Brandolini, Martina and Ingletto, Ludovica and Guerra, Massimiliano and Dirani, Giorgio and Zannoli, Silvia and Scagliarini, Alessandra and De Pascali, Alessandra Mistral and Sambri, Vittorio and Cricca, Monica},
title = {Evaluation of molecular mouse sepsis panel: new portable and rapid tests for microorganism detection in suspected blood stream infection},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1579074}
}
EUVIMED